Naloxone (Narcan) - Used to Reverse Opioid Overdose
PhysioPathoPharmaco
Naloxone (Narcan) - Used to Reverse Opioid Overdose
1:31
Urinary Tract Infection (UTI) - Diagnosis & Treatment
PhysioPathoPharmaco
Urinary Tract Infection (UTI) - Diagnosis & Treatment
4:49
Urinary Tract Infection (UTI) - Classification, Etiology, & Clinical Manifestations
PhysioPathoPharmaco
Urinary Tract Infection (UTI) - Classification, Etiology, & Clinical Manifestations
3:20
Urinary Tract Infection (UTI) - Risk Factors
PhysioPathoPharmaco
Urinary Tract Infection (UTI) - Risk Factors
4:57
Urinary Tract Infection (UTI) - Body Defense Mechanisms
PhysioPathoPharmaco
Urinary Tract Infection (UTI) - Body Defense Mechanisms
3:19
Infectious Mononucleosis or “Mono”
PhysioPathoPharmaco
Infectious Mononucleosis or “Mono”
10:14
Narcolepsy - Causes, Pathophysiology, Diagnosis, & Treatment
PhysioPathoPharmaco
Narcolepsy - Causes, Pathophysiology, Diagnosis, & Treatment
6:14
Narcolepsy & it's Symptoms
PhysioPathoPharmaco
Narcolepsy & it's Symptoms
4:22
Multiple Myeloma
PhysioPathoPharmaco
Multiple Myeloma
8:37
Drug Safety
PhysioPathoPharmaco
Drug Safety
6:55
Agonist vs. Antagonist
PhysioPathoPharmaco
Agonist vs. Antagonist
3:36
Drug Tolerance
PhysioPathoPharmaco
Drug Tolerance
5:03
Kidney - Regulation of Blood pH
PhysioPathoPharmaco
Kidney - Regulation of Blood pH
5:11
Cardiac Cycle
PhysioPathoPharmaco
Cardiac Cycle
8:46
Drug Effects & Fundamental Principles - Indication, Contraindication, Site of Action, and Mechanism
PhysioPathoPharmaco
Drug Effects & Fundamental Principles - Indication, Contraindication, Site of Action, and Mechanism
5:35
Drug Nomenclature, Naming, Scheduling, & Rx vs. OTC
PhysioPathoPharmaco
Drug Nomenclature, Naming, Scheduling, & Rx vs. OTC
3:53
Brain Hemorrhage - Epidural, Subdural, Subarachnoid, Intracerebral - Concisely Described
PhysioPathoPharmaco
Brain Hemorrhage - Epidural, Subdural, Subarachnoid, Intracerebral - Concisely Described
3:30
Stroke Types
PhysioPathoPharmaco
Stroke Types
7:50
Mechanical Bowel Obstruction
PhysioPathoPharmaco
Mechanical Bowel Obstruction
5:20
Drug Sources
PhysioPathoPharmaco
Drug Sources
3:39
Autonomic Nervous System Drugs (1.2)
PhysioPathoPharmaco
Autonomic Nervous System Drugs (1.2)
1:02:20
Conduction Pathways in the Heart
PhysioPathoPharmaco
Conduction Pathways in the Heart
5:32
Z Drugs, Melatonin Agonists, & Orexin Receptor Antagonists
PhysioPathoPharmaco
Z Drugs, Melatonin Agonists, & Orexin Receptor Antagonists
6:52
Barbiturates and Benzodiazepines
PhysioPathoPharmaco
Barbiturates and Benzodiazepines
11:07
Stages of Sleep - non-REM, REM, Sleep Studies
PhysioPathoPharmaco
Stages of Sleep - non-REM, REM, Sleep Studies
3:41
Polycystic Ovarian Syndrome (PCOS) - Pathophysiology, Symptoms, Treatment
PhysioPathoPharmaco
Polycystic Ovarian Syndrome (PCOS) - Pathophysiology, Symptoms, Treatment
7:50
Hypothalamic-Pituitary Regulation
PhysioPathoPharmaco
Hypothalamic-Pituitary Regulation
6:27
Thiazide Diuretics - Their Multiple Mechanisms & Indications
PhysioPathoPharmaco
Thiazide Diuretics - Their Multiple Mechanisms & Indications
5:18
Kidney Stones - Types, Formation, Treatment, Prevention
PhysioPathoPharmaco
Kidney Stones - Types, Formation, Treatment, Prevention
11:06
Migraines - Pathophysiology & Treatment (Described Concisely)
PhysioPathoPharmaco
Migraines - Pathophysiology & Treatment (Described Concisely)
6:58
Orthostatic Hypotension (Described Concisely)
PhysioPathoPharmaco
Orthostatic Hypotension (Described Concisely)
12:16
Analgesic Nephropathy (AN), Kidney Damage from NSAIDs
PhysioPathoPharmaco
Analgesic Nephropathy (AN), Kidney Damage from NSAIDs
2:45
Clinical Experience for Pre-PA & Pre-Med Students
PhysioPathoPharmaco
Clinical Experience for Pre-PA & Pre-Med Students
13:42
Opioid Mechanism of Action
PhysioPathoPharmaco
Opioid Mechanism of Action
5:16
Baroreceptor Reflex
PhysioPathoPharmaco
Baroreceptor Reflex
4:12
Helper T Cells
PhysioPathoPharmaco
Helper T Cells
4:31
Gate Control Theory of Pain
PhysioPathoPharmaco
Gate Control Theory of Pain
5:09
Antiemetics & Antinausea Medications
PhysioPathoPharmaco
Antiemetics & Antinausea Medications
11:45
Estrogen & Progesterone Production by Thecal & Granulosa Cells
PhysioPathoPharmaco
Estrogen & Progesterone Production by Thecal & Granulosa Cells
3:20
Mipomersen - Mechanism of Action
PhysioPathoPharmaco
Mipomersen - Mechanism of Action
2:39
Capillary Exchange & Edema
PhysioPathoPharmaco
Capillary Exchange & Edema
9:01
Hereditary Angioedema (Described Concisely) & C-1 Inhibitor Deficiency
PhysioPathoPharmaco
Hereditary Angioedema (Described Concisely) & C-1 Inhibitor Deficiency
11:43
Pain Transduction (Described Concisely)
PhysioPathoPharmaco
Pain Transduction (Described Concisely)
6:47
Platelet Plug Regulation by Endothelial Cells
PhysioPathoPharmaco
Platelet Plug Regulation by Endothelial Cells
6:33
Local Anesthetics - Mechanism, Indications & Side Effects
PhysioPathoPharmaco
Local Anesthetics - Mechanism, Indications & Side Effects
7:42
Bacterial Pneumonia - Pathogenesis
PhysioPathoPharmaco
Bacterial Pneumonia - Pathogenesis
4:36
Nitroglycerin Mechanism of Action for Angina Pectoris
PhysioPathoPharmaco
Nitroglycerin Mechanism of Action for Angina Pectoris
8:06
Platelet Plug Formation - Mechanisms
PhysioPathoPharmaco
Platelet Plug Formation - Mechanisms
4:19
Gout - Mechanisms & Treatment
PhysioPathoPharmaco
Gout - Mechanisms & Treatment
7:14
Hepatic Encephalopathy and Lactulose
PhysioPathoPharmaco
Hepatic Encephalopathy and Lactulose
3:57
Visual Neural Pathways and Visual Field Defects
PhysioPathoPharmaco
Visual Neural Pathways and Visual Field Defects
5:29
Simple Diffusion, Facilitated Diffusion, Primary Active Transport, & Secondary Active Transport
PhysioPathoPharmaco
Simple Diffusion, Facilitated Diffusion, Primary Active Transport, & Secondary Active Transport
8:52
Bioavailability and First Pass Metabolism
PhysioPathoPharmaco
Bioavailability and First Pass Metabolism
4:39
The Neuromuscular Junction (Described Concisely)
PhysioPathoPharmaco
The Neuromuscular Junction (Described Concisely)
6:14
Diffusion & Osmosis
PhysioPathoPharmaco
Diffusion & Osmosis
13:22
Alzheimer's Disease - plaques, tangles, pathogenesis, risk factors, disease progression
PhysioPathoPharmaco
Alzheimer's Disease - plaques, tangles, pathogenesis, risk factors, disease progression
11:43
Type IV Hypersensitivity (Described Concisely)
PhysioPathoPharmaco
Type IV Hypersensitivity (Described Concisely)
6:33
Lipid & Lipoprotein Processing Part 3 - Formation of LDL and HDL
PhysioPathoPharmaco
Lipid & Lipoprotein Processing Part 3 - Formation of LDL and HDL
4:19
Polycythemia - Part 2
PhysioPathoPharmaco
Polycythemia - Part 2
9:25
Polycythemia
PhysioPathoPharmaco
Polycythemia
9:36
Type III Hypersensitivity
PhysioPathoPharmaco
Type III Hypersensitivity
4:42
Type II Hypersensitivity - Mechanisms (Described Concisely)
PhysioPathoPharmaco
Type II Hypersensitivity - Mechanisms (Described Concisely)
8:33
Hereditary Spherocytosis (HS) - Pathophysiology
PhysioPathoPharmaco
Hereditary Spherocytosis (HS) - Pathophysiology
9:49
Painful Bladder Syndrome (PBS) / Interstitial Cystitis (IC)
PhysioPathoPharmaco
Painful Bladder Syndrome (PBS) / Interstitial Cystitis (IC)
8:41
Type I Hypersensitivity - Mechanism (Described Concisely)
PhysioPathoPharmaco
Type I Hypersensitivity - Mechanism (Described Concisely)
6:05
Anticoagulants - Naturally Occuring
PhysioPathoPharmaco
Anticoagulants - Naturally Occuring
3:35
Metabolism - Part 2 - Glycolysis and Lactic Acid Fermentation
PhysioPathoPharmaco
Metabolism - Part 2 - Glycolysis and Lactic Acid Fermentation
5:42
Parkinson's Disease
PhysioPathoPharmaco
Parkinson's Disease
14:39
Pseudobulbar Affect (PBA) - Part 2 - Treatment
PhysioPathoPharmaco
Pseudobulbar Affect (PBA) - Part 2 - Treatment
5:09
Pseudobulbar Affect (PBA) - Part 1 - Symptoms & Differences from Depression
PhysioPathoPharmaco
Pseudobulbar Affect (PBA) - Part 1 - Symptoms & Differences from Depression
4:18
Muscle Relaxers - Mechanisms, Indications, Side Effects
PhysioPathoPharmaco
Muscle Relaxers - Mechanisms, Indications, Side Effects
7:18
Dantrolene & Calcium Channel Blockers (CCBs)
PhysioPathoPharmaco
Dantrolene & Calcium Channel Blockers (CCBs)
7:29
Dihydropyridine & Ryanodine Channels - Excitation/Contraction Coupling
PhysioPathoPharmaco
Dihydropyridine & Ryanodine Channels - Excitation/Contraction Coupling
2:14
Acute Kidney Injury (AKI) - Prerenal,Intrarenal,Postrenal
PhysioPathoPharmaco
Acute Kidney Injury (AKI) - Prerenal,Intrarenal,Postrenal
10:45
BUN and Creatinine
PhysioPathoPharmaco
BUN and Creatinine
5:26
Guillain-Barre Syndrome (GBS) (Described Concisely)
PhysioPathoPharmaco
Guillain-Barre Syndrome (GBS) (Described Concisely)
12:30
Autonomic Nervous System
PhysioPathoPharmaco
Autonomic Nervous System
11:17
Metabolism - Part 1 - Overview of Cellular Respiration
PhysioPathoPharmaco
Metabolism - Part 1 - Overview of Cellular Respiration
8:16
Acute Leukemia - Part 1
PhysioPathoPharmaco
Acute Leukemia - Part 1
9:20
Diuretics - Part 1 - Osmotic Diuretics & Carbonic Anhydrase Inhibitors
PhysioPathoPharmaco
Diuretics - Part 1 - Osmotic Diuretics & Carbonic Anhydrase Inhibitors
7:01
Diuretics - Part 2 - Loops, Thiazides, K+ Sparing, and ADH antagonists
PhysioPathoPharmaco
Diuretics - Part 2 - Loops, Thiazides, K+ Sparing, and ADH antagonists
9:05
Panacea-Med Live Stream
PhysioPathoPharmaco
Panacea-Med Live Stream
Lipid & Lipoprotein Processing Part 2 - Chylomicron Metabolism
PhysioPathoPharmaco
Lipid & Lipoprotein Processing Part 2 - Chylomicron Metabolism
4:22
Leukemia - Overview
PhysioPathoPharmaco
Leukemia - Overview
6:34
Electrophysiology Part 2 - Affecting the Resting Membrane Potential
PhysioPathoPharmaco
Electrophysiology Part 2 - Affecting the Resting Membrane Potential
9:18
Regulation of Insulin Release and Insulin Action
PhysioPathoPharmaco
Regulation of Insulin Release and Insulin Action
3:20
Thyroid Part 2 - Thyroid Hormone Synthesis
PhysioPathoPharmaco
Thyroid Part 2 - Thyroid Hormone Synthesis
9:44
Thyroid Part 1 - Thyroid Gland Structure and Calcitonin
PhysioPathoPharmaco
Thyroid Part 1 - Thyroid Gland Structure and Calcitonin
2:21
Electrophysiology Part 1 - The Resting Membrane Potential (RMP) & Action Potentials
PhysioPathoPharmaco
Electrophysiology Part 1 - The Resting Membrane Potential (RMP) & Action Potentials
12:14
Adaptive Immunity Part 2 - Cell-mediated
PhysioPathoPharmaco
Adaptive Immunity Part 2 - Cell-mediated
6:36
Adaptive Immunity Part 1 - Humoral Immunity
PhysioPathoPharmaco
Adaptive Immunity Part 1 - Humoral Immunity
6:55
The Inflammatory Response
PhysioPathoPharmaco
The Inflammatory Response
8:06
Pathogenesis of Atherosclerosis
PhysioPathoPharmaco
Pathogenesis of Atherosclerosis
6:06
Philadelphia Chromosome, Translocations, Inversions, Deletions
PhysioPathoPharmaco
Philadelphia Chromosome, Translocations, Inversions, Deletions
4:15
Phagocytosis
PhysioPathoPharmaco
Phagocytosis
2:25
Hemoglobin Breakdown/Metabolism
PhysioPathoPharmaco
Hemoglobin Breakdown/Metabolism
7:52
Celiac Disease Pathogenesis (Described Concisely and in Detail)
PhysioPathoPharmaco
Celiac Disease Pathogenesis (Described Concisely and in Detail)
9:53
Parietal Cell Acid Production
PhysioPathoPharmaco
Parietal Cell Acid Production
5:12
Muscular Dystrophy
PhysioPathoPharmaco
Muscular Dystrophy
8:12
H Pylori and Ulcers
PhysioPathoPharmaco
H Pylori and Ulcers
7:22